🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Felix Y. Feng

Cisco Systems (China)

ORCID: 0000-0001-9756-4037

Also affiliated with German Cancer Research Center, University of California, San Francisco, Heidelberg University, Fred Hutch Cancer Center, Universidad Católica de Santa Fe, UCSF Helen Diller Family Comprehensive Cancer Center, University of San Francisco

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol”.

External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol

The Lancet Digital Health(2025)10.1016/j.landig.2025.100885
N/A
0.573DataRank · unranked
17 citations

Larissa Mendes, Vinnie Y.T. Liu, Emily Grist, Songwan Joun, Rikiya Yamashita +35 more

Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer

JCI Insight(2023)10.1172/jci.insight.162907
N/A
0DataRank · unranked
82 citations

Radhika A. Patel, Ilsa M. Coleman, Martine P. Roudier, Ailin Zhang, Pallabi Mustafi +20 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730.v1
N/A
0DataRank · unranked
0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome

JCI Insight(2022)10.1172/jci.insight.157164
N/A
0DataRank · unranked
19 citations

Lisha G. Brown, Jennifer L. Conner, Holly M. Nguyen, Nadia Boufaied, Sarah Abou Alaiwi +15 more

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials

European Urology Oncology(2024)10.1016/j.euo.2024.10.017
N/A
0DataRank · unranked
2 citations

Paul L. Nguyen, James A. Proudfoot, Yang Liu, Alan Dal Pra, Daniel E. Spratt +16 more

Identification and Characterization of PLUTO-201, a Novel Long Non-Coding RNA Associated with Poor Outcomes in Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.21.655369
N/A
0DataRank · unranked
0 citations

Noah Younger, Bhavna Malik, Hyun Jin Shin, Chao Zhang, Yashar Niknafs +24 more

Digital Pathology–based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.11.009
N/A
0DataRank · unranked
13 citations

Yi Ren, Meghan Tierney, Trevor J. Royce, Rikiya Yamashita, Danielle Croucher +13 more